These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5059580)

  • 21. Antiarrhythmic effects of tocainide and lidocaine in dogs.
    Aberg G; Ronfeld R; Aberg L; Fitzgerald T; McCollom K; Moller R
    Acta Pharmacol Toxicol (Copenh); 1983 Aug; 53(2):146-52. PubMed ID: 6414246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of antiarrhythmic agents during acute myocardial ischemia and the role of heart rate.
    Hope RR; Williams DO; el-Sherif N; Lazzara R; Scherlag BJ
    Circulation; 1974 Sep; 50(3):507-14. PubMed ID: 4416250
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of lidocaine on systemic and coronary hemodynamics.
    Thomsen JH; Terry W; Stenlund RR; Querimit S; Rowe GG
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):83-92. PubMed ID: 5123869
    [No Abstract]   [Full Text] [Related]  

  • 24. The acute antiarrhythmic and toxic effects in mice and dogs of 2-ethylamino-2',6-'acetoxylidine (L-86), a metabolite of lidocaine.
    Smith ER; Duce BR
    J Pharmacol Exp Ther; 1971 Dec; 179(3):580-5. PubMed ID: 5138029
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of ventricular arrhythmias with mexiletine (Kö 1173).
    Talbot RG; Nimmo J; Julian DG; Clark RA; Neilson JM; Prescott LF
    Lancet; 1973 Aug; 2(7826):399-404. PubMed ID: 4124889
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs.
    Matsuzaki T; Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Feb; 231(3):363-70. PubMed ID: 8449229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between plasma lignocaine levels and induced haemodynamic changes.
    Binnion PF; Murtagh G; Pollock AM; Fletcher E
    Br Med J; 1969 Aug; 3(5667):390-2. PubMed ID: 5797780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lidocaine for ventricular arrhythmias in acute myocardial infarction.
    Malach M; Kostis JB; Fischetti JL
    Am J Med Sci; 1969 Jan; 257(1):52-60. PubMed ID: 5763612
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostaglandin E 1 and cardiac arrhythmia.
    Zijlstra WG; Brunsting JR; ten Hoor F; Vergroesen AJ
    Eur J Pharmacol; 1972 May; 18(3):392-5. PubMed ID: 5035626
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of lidocaine by continuous infusion.
    Bassan MM; Weinstein SR; Mandel WJ
    Am Heart J; 1974 Mar; 87(3):302-3. PubMed ID: 4812367
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of prostaglandins on late coronary ligation arrhythmias in the dog.
    Hashimoto K; Shibuya T; Imai S
    Jpn J Pharmacol; 1983 Oct; 33(5):1035-9. PubMed ID: 6358586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bupivacaine-induced cardiac arrhythmias in sheep.
    Kotelko DM; Shnider SM; Dailey PA; Brizgys RV; Levinson G; Shapiro WA; Koike M; Rosen MA
    Anesthesiology; 1984 Jan; 60(1):10-8. PubMed ID: 6691590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of myocardial infarct volume. An experimental study in the dog.
    Pierce WS; Carter DR; McGavran MH; Waldhausen JA
    Arch Surg; 1973 Nov; 107(5):682-7. PubMed ID: 4126701
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of glucagon on ventricular arrhythmias after coronary artery occlusion and on ventricular automaticity in the dog.
    Madan BR
    Br J Pharmacol; 1971 Oct; 43(2):279-86. PubMed ID: 5158198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lidocaine and arrhythmias].
    Bastaroli JC; Castagnino HE
    Medicina (B Aires); 1972; 32(2):168-82. PubMed ID: 4556899
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of selectivity for ventricular and ischaemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischaemia-induced arrhythmias.
    Barrett TD; Hayes ES; Walker MJ
    Eur J Pharmacol; 1995 Oct; 285(3):229-38. PubMed ID: 8575508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antiarrhythmic properties of lidocaine and propranolol: a review.
    Gianelly RE; Harrison DC
    Geriatrics; 1970 Apr; 25(4):120-8. PubMed ID: 4910274
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiac and peripheral vascular effects of lidocaine and procainamide.
    Austen WG; Moran JM
    Am J Cardiol; 1965 Nov; 16(5):701-7. PubMed ID: 5837148
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of intravenous lidocaine on heart rate, systolic arterial blood pressure and cough responses to endotracheal intubation in propofol-anaesthetized dogs.
    Jolliffe CT; Leece EA; Adams V; Marlin DJ
    Vet Anaesth Analg; 2007 Sep; 34(5):322-30. PubMed ID: 17490467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.